3 completed, 3 recruiting, 3 terminated, 3 unknown. 5 Phase 2, 3 Not applicable, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 2, Unknown 2, Active not recruiting 1 |
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Recruiting 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Concurrent chemoradiation: new trials by email Literature Review of Concurrent chemoradiation trials Research Report on Concurrent chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thermotherapy for Head and Neck Cancer Patients Thermotherapy, Radiotherapy, Concurrent chemoradiation - Head and Neck Cancer, Oropharyngeal Carcinoma | Phase 1 | Recruiting | Erasmus Medical Center | 30 | 2026-09-01 | 2026-09-02 |
| Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02) Tislelizumab, Carboplatin, Nab-paclitaxel - Esophageal Squamous Cell Carcinoma (ESCC) | Phase 1 | Recruiting | Shanghai Zhongshan Hospital | 60 | 2025-07-15 | 2026-01-05 |
| Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer Concurrent chemoradiation - Breast Cancer | Unknown | Assiut University | 46 | 2023-09-01 | 2022-10-18 | |
| Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer Concurrent chemoradiation, Open/minimally invasive para-aortic lymph node dissection followed by concurrent chemoradiation - Locally Advanced Cervical Cancer | Not applicable | Recruiting | Chongqing University Cancer Hospital | 1956 | 2022-06-27 | 2023-08-31 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer Oxaliplatin, Tegafur-Gimeracil-Oteracil, Sintilimab - Stomach Neoplasms, Esophagogastric Junction Disorder | Phase 2 | Terminated | Fudan University | 6 | 2021-09-28 | 2025-06-18 |
| Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma Anlotinib hydrochloride, induction chemotherapy, concurrent chemoradiation - Nasopharyngeal Carcinoma | Phase 2 | Unknown | Zhejiang Cancer Hospital | 37 | 2021-01-01 | 2022-02-10 |
| NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer Pembrolizumab - NPC | Phase 2 | Active not recruiting | Chinese University of Hong Kong | 43 | 2019-05-03 | 2025-12-24 |
| The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) PET/CT, Radiotherapy, Concurrent Chemoradiation - Human Papilloma Virus, Oropharyngeal Squamous Cell Carcinoma | Not applicable | Completed | Icahn School of Medicine at Mount Sinai | 112 | 2014-03-01 | 2024-05-06 |
| Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma Radiotherapy alone, Concurrent chemoradiation - Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | Terminated | Fudan University | 4 | 2012-06-01 | 2013-03-05 |
| Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients concurrent chemoradiation - Gastric Cancer | Phase 2 | Unknown | Chinese Academy of Medical Sciences | 40 | 2011-10-01 | 2015-02-05 |
| Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors concurrent chemoradiation - Thymoma and Thymic Carcinoma | Not applicable | Completed | Fudan University | 56 | 2011-06-01 | 2020-02-07 |
| Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer concurrent chemoradiation - Colorectal Cancer | Completed | Mackay Memorial Hospital | 30 | 2006-04-01 | 2017-03-22 | |
| Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers Concurrent Chemoradiation, Laryngectomy + adjuvant radiotherapy/chemoradiotherapy - Larynx Neoplasms | Phase 3 | Terminated | Tata Memorial Hospital | 900 | 2005-05-01 | 2013-01-23 |
Laryngeal Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Head and Neck Neoplasms (1) · Hyperthermia (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Diseases (1) · Lymphoma, Extranodal NK-T-Cell (1) · Mouth Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Neoplasms (1)
Fudan University (3) · Assiut University (1) · Chinese Academy of Medical Sciences (1) · Chinese University of Hong Kong (1) · Chongqing University Cancer Hospital (1) · Erasmus Medical Center (1) · Icahn School of Medicine at Mount Sinai (1) · Mackay Memorial Hospital (1) · Shanghai Zhongshan Hospital (1) · Tata Memorial Hospital (1) · Zhejiang Cancer Hospital (1)
China (7) · Hong Kong (1) · India (1) · Netherlands (1) · Singapore (1) · Taiwan (1) · United States (1)
Dongling Zou, M.D. (1) · Kailiang Wu, M.D.,Ph.D (1) · Marshall Posner, MD (1) · Michiel Kroesen, MD, Dr. (1) · Prathamesh S Pai, MS,DNB,DORL (1) · Raymond Chai, MD (1) · Ye Guo, MD (1) · Yu-Jen Chen, MD, PhD (1)
PMID 12049861, PMID 16794899, PMID 23401019, PMID 26254683, PMID 26808342, PMID 29409469, PMID 29441562, PMID 29861116, PMID 31319389, PMID 32143580, PMID 33065643, PMID 34137505, PMID 34454674, PMID 35671803, PMID 35764956, PMID 36158679, PMID 36322089, PMID 37433041